Hyperthermia used in combination with radiotherapy or chemotherapy is becoming an established modality for the treatment of cancer. Although malignant cells are not necessarily more heat-sensitive than normal cells, tumors are generally more vulnerable to heat than are normal tissues. It is believed that the intrinsic difference in the vascular structure as well as the thermal response of vasculature and related physiological and metabolic factors in tumors and normal tissues is the main cause of such preferential effect of hyperthermia on tumors. Specifically, the temperature in tumors tends to rise higher than that in adjacent normal tissues during heating, owing to the inefficient heat dissipation by the sluggish blood flow in the tumors relative to that in the normal tissues. It has been known that the thermosensitivity of mammalian cells is profoundly enhanced by acidic and poor nutritional conditions. Interestingly, the intratumor environment is acidic and nutritionally deprived. This condition is further enhanced in the heated tumor probably due to vascular function and related physiological and biochemical factors for the effective use of hyperthermia. The longterm objective of this sutdy is to further understand the role of blood flow and related microenvironment in the hyperthermic treatment of cancer.
The specific aim of this application is to elucidate the heatinduced vascular changes in normal internal organs. The heatedinduced change in blood flow in cutaneous tissue has been extensively studied, but the effect of heat on the blood flow in other normal tissues, including the organs in the body cavity, is virtually unknown. This may be attributed to the fact that a suitable device to heat the deep internal organs has not been available. We recently acquired a capacitive heating device capable of heating deep internal organs of experimental animals. We propose to investigate the effect of heat on the blood flow and also determine the threshold thermal dose for vascular damage in various internal organs of rats. The blood flow will be measured with the radioactive microsphere method, which has long been established in our laboratory. We strongly believe the information obtained in this study will provide a rationale basis on which an effective use of hyperthermia to treat deepseated human tumors can be planned.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA044114-02
Application #
3186662
Study Section
Diagnostic Radiology Study Section (RNM)
Project Start
1987-01-01
Project End
1989-12-31
Budget Start
1988-01-01
Budget End
1988-12-31
Support Year
2
Fiscal Year
1988
Total Cost
Indirect Cost
Name
University of Minnesota Twin Cities
Department
Type
Schools of Medicine
DUNS #
168559177
City
Minneapolis
State
MN
Country
United States
Zip Code
55455
Jenkins, Samir V; Nedosekin, Dmitry A; Miller, Emily K et al. (2018) Galectin-1-based tumour-targeting for gold nanostructure-mediated photothermal therapy. Int J Hyperthermia 34:19-29
Koonce, Nathan A; Juratli, Mazen A; Cai, Chengzhong et al. (2017) Real-time monitoring of circulating tumor cell (CTC) release after nanodrug or tumor radiotherapy using in vivo flow cytometry. Biochem Biophys Res Commun 492:507-512
Song, Chang W; Lee, Yoon-Jin; Griffin, Robert J et al. (2015) Indirect Tumor Cell Death After High-Dose Hypofractionated Irradiation: Implications for Stereotactic Body Radiation Therapy and Stereotactic Radiation Surgery. Int J Radiat Oncol Biol Phys 93:166-72
Koonce, Nathan A; Quick, Charles M; Hardee, Matthew E et al. (2015) Combination of Gold Nanoparticle-Conjugated Tumor Necrosis Factor-? and Radiation Therapy Results in a Synergistic Antitumor Response in Murine Carcinoma Models. Int J Radiat Oncol Biol Phys 93:588-96
Koonce, Nathan A; Levy, Joseph; Hardee, Matthew E et al. (2015) Targeting Artificial Tumor Stromal Targets for Molecular Imaging of Tumor Vascular Hypoxia. PLoS One 10:e0135607
Przybyla, Beata D; Shafirstein, Gal; Vishal, Sagar J et al. (2014) Molecular changes in bone marrow, tumor and serum after conductive ablation of murine 4T1 breast carcinoma. Int J Oncol 44:600-8
Kim, Jin-Woo; Galanzha, Ekaterina I; Zaharoff, David A et al. (2013) Nanotheranostics of circulating tumor cells, infections and other pathological features in vivo. Mol Pharm 10:813-30
Shenoi, Mithun M; Iltis, Isabelle; Choi, Jeunghwan et al. (2013) Nanoparticle delivered vascular disrupting agents (VDAs): use of TNF-alpha conjugated gold nanoparticles for multimodal cancer therapy. Mol Pharm 10:1683-94
Shao, Jingwei; Griffin, Robert J; Galanzha, Ekaterina I et al. (2013) Photothermal nanodrugs: potential of TNF-gold nanospheres for cancer theranostics. Sci Rep 3:1293
Upreti, Meenakshi; Jamshidi-Parsian, Azemat; Apana, Scott et al. (2013) Radiation-induced galectin-1 by endothelial cells: a promising molecular target for preferential drug delivery to the tumor vasculature. J Mol Med (Berl) 91:497-506

Showing the most recent 10 out of 103 publications